NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: An FDA phase-II prospective, randomized clinical trial after two years

Journal of Bone and Joint Surgery

Volumn 94, Issue 11, 2012, Pages 979-989

  Crawford, Dennis C ^a   DeBerardino, Thomas M ^b   Williams III, Riley J ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; TISSUE SCAFFOLD;

ADULT; ARTHROSCOPY; ARTICLE; AUTOGRAFT; AUTOLOGOUS CARTILAGE TISSUE IMPLANT; BODY MASS; CARTILAGE BIOPSY; CARTILAGE CELL; CARTILAGE GRAFT; CARTILAGE INJURY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; KNEE ARTICULAR CARTILAGE INJURY; KNEE FUNCTION; KNEE INJURY; KNEE PAIN; MALE; MEDICAL SOCIETY; MICROFRACTURE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHORT FORM 36; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

EID: 84863594682     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.00533     Document Type: Article

References (46)

1. Brandt KD, Dieppe P, Radin E. Etiopathogenesis of osteoarthritis. Med Clin North Am. 2009;93:1-24,xv.
2. Lane NE. Clinical practice. Osteoarthritis of the hip. N Engl J Med. 2007;357:1413-21.
3. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331:889-95. (Pubitemid 24299869)
4. Krishnan SP, Skinner JA, Carrington RW, Flanagan AM, Briggs TW, Bentley G. Collagen-covered autologous chondrocyte implantation for osteochondritis dissecans of the knee: two- to seven-year results. J Bone Joint Surg Br. 2006;88:203-5. (Pubitemid 43279931)
5. Bartlett W, Skinner JA, Gooding CR, Carrington RW, Flanagan AM, Briggs TW, Bentley G. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br. 2005;87:640-5. (Pubitemid 40711636)
6. Peterson L, Minas T, Brittberg M, Nilsson A, Sjögren-Jansson E, Lindahl A. Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop Relat Res. 2000;374:212-34. (Pubitemid 30263488)
7. Peterson L, Vasiliadis HS, Brittberg M, Lindahl A. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med. 2010;38:1117-24.
8. Minas T. Autologous chondrocyte implantation for focal chondral defects of the knee. Clin Orthop Relat Res. 2001;391Suppl:S349-61. (Pubitemid 32954038)
9. Vasiliadis HS, Wasiak J. Autologous chondrocyte implantation for full thickness articular cartilage defects of the knee. Cochrane Database Syst Rev. 2010;10:CD003323.
10. Knutsen G, Drogset JO, Engebretsen L, Grøntvedt T, Isaksen V, Ludvigsen TC, Roberts S, Solheim E, Strand T, Johansen O. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89:2105-12. (Pubitemid 47606154)
11. Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grøntvedt T, Solheim E, Strand T, Roberts S, Isaksen V, Johansen O. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am. 2004;86:455-64. (Pubitemid 38269014)
12. Saris DB, Vanlauwe J, Victor J, Haspl M, Bohnsack M, Fortems Y, Vandekerckhove B, Almqvist KF, Claes T, Handelberg F, Lagae K, van der Bauwhede J, Vandenneucker H, Yang KG, Jelic M, Verdonk R, Veulemans N, Bellemans J, Luyten FP. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med. 2008;36:235-46.
13. Wood JJ, Malek MA, Frassica FJ, Polder JA, Mohan AK, Bloom ET, Braun MM, Coté TR. Autologous cultured chondrocytes: adverse events reported to the United States Food and Drug Administration. J Bone Joint Surg Am. 2006;88:503-7.
14. Tuan RS. A second-generation autologous chondrocyte implantation approach to the treatment of focal articular cartilage defects. Arthritis Res Ther. 2007;9:109.
15. Blahut EB, Kusanagi A, Mascarenhas AC, Johnson J, Berlowitz-Tarrant LJ, Mizuno S. Effects of medium flow rate on extracellular matrix accumulation by swine articular chondrocyte in collagen sponges [abstract]. In: Transactions of the 49th Annual Orthopaedic Research Society; 2003 Feb 2-5; New Orleans, LA. Rosemont, IL: Orthopaedic Research Society; 2003. p 0634.
16. Mascarenhas AC, Kusanagi A, Blahut EB, Johnson J, Berlowitz-Tarrant LJ, Mizuno S. Hydrostatic pressure stimulates extracellular matrix accumulation by swine articular chondrocytes in 3D collagen sponges [abstract]. In: Transactions of the 49th Annual Orthopaedic Research Society; 2003 Feb 2-5; New Orleans, LA. Rosemont, IL: Orthopaedic Research Society; 2003. p 0127.
17. Hettrich CM, Crawford D, Rodeo SA. Cartilage repair: third-generation cell-based technologies - basic science, surgical techniques, clinical outcomes. Sports Med Arthrosc. 2008;16:230-5.
18. Crawford DC, Heveran CM, Cannon WD Jr, Foo LF, Potter HG. An autologous cartilage tissue implant NeoCart for treatment of grade III chondral injury to the distal femur: prospective clinical safety trial at 2 years. Am J Sports Med. 2009;37:1334-43.
19. Alford JW, Cole BJ. Cartilage restoration, part 2: techniques, outcomes, and future directions. Am J Sports Med. 2005;33:443-60. (Pubitemid 40270884)
20. Cole BJ, Pascual-Garrido C, Grumet RC. Surgical management of articular cartilage defects in the knee. J Bone Joint Surg Am. 2009;91:1778-90.
21. Steadman JR, Rodkey WG, Singleton SB, Briggs KK. Microfracture technique for full-thickness chondral defects: technique and clinical results. Oper Tech Orthop. 1997;7:300-4. (Pubitemid 127682393)
22. Mithoefer K, Williams RJ 3rd, Warren RF, Potter HG, Spock CR, Jones EC, Wickiewicz TL, Marx RG. Chondral resurfacing of articular cartilage defects in the knee with the microfracture technique. Surgical technique. J Bone Joint Surg Am. 2006;88 Suppl. 1 Pt 2:294-304.
23. Williams RJ 3rd, Harnly HW. Microfracture: indications, technique, and results. Instr Course Lect. 2007;56:419-28.
24. Mithoefer K, Williams RJ 3rd, Warren RF, Potter HG, Spock CR, Jones EC, Wickiewicz TL, Marx RG. The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. J Bone Joint Surg Am. 2005;87:1911-20. (Pubitemid 41279120)
25. Irrgang JJ, Anderson AF, Boland AL, Harner CD, Kurosaka M, Neyret P, Richmond JC, Shelborne KD. Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med. 2001;29:600-13. (Pubitemid 32885251)
26. Greco NJ, Anderson AF, Mann BJ, Cole BJ, Farr J, Nissen CW, Irrgang JJ. Responsiveness of the International Knee Documentation Committee Subjective Knee Form in comparison to the Western Ontario and McMaster Universities Osteoarthritis Index, modified Cincinnati Knee Rating System, and Short Form 36 in patients with focal articular cartilage defects. Am J Sports Med. 2010;38:891-902.
27. Roos EM, Engelhart L, Ranstam J, Anderson AF, Irrgang JJ, Marx RG, Tegner Y, Davis AM. ICRS recommendation document: patient-reported outcome instruments for use in patients with articular cartilage defects. Cartilage. 2011;2:122-36.
28. Bekkers JE, de Windt TS, Raijmakers NJ, Dhert WJ, Saris DB. Validation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) for the treatment of focal cartilage lesions. Osteoarthritis Cartilage. 2009;17:1434-9.
29. Roos EM, Lohmander LS. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health Qual Life Outcomes. 2003;1:64.
30. Snapinn SM, Jiang Q. Responder analyses and the assessment of a clinically relevant treatment effect. Trials. 2007;8:31.
31. Mithoefer K, McAdams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med. 2009;37:2053-63.
32. Kon E, Gobbi A, Filardo G, Delcogliano M, Zaffagnini S, Marcacci M. Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years. Am J Sports Med. 2009;37:33-41.
33. Van Assche D, Van Caspel D, Vanlauwe J, Bellemans J, Saris DB, Luyten FP, Staes F. Physical activity levels after characterized chondrocyte implantation versus microfracture in the knee and the relationship to objective functional outcome with 2-year follow-up. Am J Sports Med. 2009;37 Suppl. 1:42S-49S.
34. Saris DB, Vanlauwe J, Victor J, Almqvist KF, Verdonk R, Bellemans J, Luyten FP; TIG/ACT/01/2000&EXT Study Group. Treatment of symptomatic cartilage defects of the knee: characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med. 2009;37 Suppl. 1:10S-19S.
35. Kusanagi A, Johnson J, Blahut EB, Mascarenhas AC, Mizuno S. Hydrostatic pressure suppresses long term degradation of matrix accumulated by porcine articular chondrocytes in 3D collagen gel/sponges [abstract]. In: Transactions of the 50th Annual Orthopaedic Research Society; 2004 Mar 7-10; San Francisco, CA. Rosemont, IL: Orthopaedic Research Society; 2004. p 0726.
36. Kusanagi A, Blahut EB, Johnson JM, Mascarehas AC, Murata T, Tsuchiya A, Mochizuki M, Mizuno S. Cartilage repair with engineered chondrocyte constructs: a 6 month study in a swine model [abstract]. In: Transactions of the 51st Annual Orthopaedic Research Society; 2005 Feb 20-3; Washington, DC. Rosemont, IL: Orthopaedic Research Society; 2005. p 0302.
37. Kusanagi A, Mascarenhas AC, Blahut EB, Johnson JM, Murata T, Mizuno S. Hydrostatic pressure with low oxygen stimulates extracellular matrix accumulation by human articular chondrocytes in a 3-D collagen gel/sponge [abstract]. In: Transactions of the 51st Annual Orthopaedic Research Society; 2005 Feb 20-3; Washington, DC. Rosemont, IL: Orthopaedic Research Society; 2005. p 0384.
38. Kreuz PC, Steinwachs MR, Erggelet C, Krause SJ, Knorad G, Uhl M, Südkamp N. Results after microfracture of full-thickness chondral defects in different compartments of the knee. Osteoarthritis Cartilage. 2006;14:1119-25. (Pubitemid 44490314)
39. Dumville JC, Hahn S, Miles JN, Torgerson DJ. The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials. 2006;27:1-12. (Pubitemid 41758434)
40. Farrar JT, Dworkin RH, Max MB. Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. J Pain Symptom Manage. 2006;31:369-77.
41. Burkhoff D, Parides M, Borggrefe M, Abraham WT, Kadish A. "Responder analysis" for assessing effectiveness of heart failure therapies based on measures of exercise tolerance. J Card Fail. 2009;15:108-15.
42. U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.
43. Eron J Jr, Yeni P, Gathe J Jr, Estrada V, DeJesus E, Staszewski S, Lackey P, Katlama C, Young B, Yau L, Sutherland-Phillips D, Wannamaker P, Vavro C, Patel L, Yeo J, Shaefer M; KLEAN study team. The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial. Lancet. 2006;368:476-82. (Pubitemid 44160731)
44. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006;367:29-35. (Pubitemid 43038667)
45. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572-81. (Pubitemid 38758544)
46. McMillan-Price J, Petocz P, Atkinson F, O'neill K, Samman S, Steinbeck K, Caterson I, Brand-Miller J. Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: a randomized controlled trial. Arch Intern Med. 2006;166:1466-75. (Pubitemid 44125865)